The recent proceedings of the World Health Assembly (WHA) have marked a pivotal moment in international public health, characterized by a series of decisive actions aimed at shoring up the global response to both historic infectious threats and modern, chronic diseases. As global leaders gathered, the agenda underscored a sobering reality: while scientific progress has saved millions of lives, systemic issues—ranging from climate change and underfunding to the rapid spread of digital misinformation—threaten to undo decades of advancement.
From the urgent drive to draft a post-2030 tuberculosis strategy to the recognition of steatotic liver disease as a burgeoning crisis, the Assembly has set a comprehensive, albeit demanding, roadmap for the remainder of the decade.
The Path Beyond 2030: A New Global Strategy for Tuberculosis
Main Facts and Strategic Mandate
In a landmark decision, the Assembly officially requested that the WHO Director-General formulate a comprehensive strategy to eradicate tuberculosis (TB) beyond 2030. This new framework is slated for presentation at the Eighty-first World Health Assembly in 2028. This move is not merely administrative; it is a calculated effort to synchronize the global TB response with modern epidemiological trends and the latest scientific breakthroughs.
The strategy aims to bridge the gap between vertical disease-control programs and the broader objectives of Universal Health Coverage (UHC) and primary health care. By integrating TB care into these foundational systems, the WHO intends to ensure that the response is resilient, sustainable, and better prepared for the 2028 United Nations High-Level Meeting on TB.
The Chronology of Progress and Setbacks
The discussion was framed by a report on the current End TB Strategy. The data paints a complex picture of the last quarter-century:
- 2000–2024: An estimated 83 million lives were saved through the expansion of essential TB treatment programs.
- 2024: A milestone year that recorded the first post-pandemic decline in TB incidence alongside the highest levels of patient access to essential services ever documented.
However, these gains are fragile. The report highlighted that despite these achievements, TB remains one of the world’s deadliest infectious killers. Global targets under the 2030 Agenda for Sustainable Development are currently "off track." The reasons for this stagnation are multifaceted: chronic underfunding, the lingering impact of pandemic-related service disruptions, rising inequality, and the destabilizing effects of conflict and climate-driven displacement.
The Silent Epidemic: Confronting Steatotic Liver Disease (SLD)
Recognizing a Global NCD Crisis
In a significant policy shift, the Assembly approved a resolution formally recognizing steatotic liver disease (SLD)—formerly known as fatty liver disease—as a major, escalating burden within the landscape of noncommunicable diseases (NCDs).
With an estimated 1.7 billion people affected globally, SLD is now recognized as one of the fastest-growing causes of chronic liver conditions. The condition serves as a bellwether for the broader NCD crisis, as it is intrinsically linked to obesity, type 2 diabetes, and cardiovascular disease. Furthermore, alcohol-associated liver disease continues to contribute significantly to the total global burden of liver-related morbidity.
Implications for Health Systems
The danger of SLD lies in its progression. Without effective early intervention, it advances toward liver fibrosis, cirrhosis, and ultimately, liver cancer. The Assembly’s resolution mandates a paradigm shift in how countries manage this condition:
- Integration: SLD must be integrated into national NCD strategies rather than treated in isolation.
- Multisectoral Action: Addressing the root causes—unhealthy diets, physical inactivity, and the harmful use of alcohol—is non-negotiable.
- Proactive Screening: There is a renewed focus on high-risk populations, specifically targeting children and adolescents to prevent the long-term, costly complications of late-stage disease.
The WHO has been tasked with providing technical support and monitoring progress through biennial reports, ensuring that the global response to SLD is as robust as the response to other major NCDs.
Closing the Equity Gap: Haemophilia and Bleeding Disorders
A Call for Global Inclusion
For decades, the community of people living with haemophilia and other rare bleeding disorders has faced a profound "equity gap." With nearly 70% of those living with haemophilia remaining undiagnosed globally, the Assembly’s new resolution serves as a long-awaited commitment to universal care.
Haemophilia and related conditions, such as von Willebrand Disease, impair the body’s ability to clot blood. Without timely diagnosis and regular prophylaxis, patients face chronic disability, severe health complications, and a significantly diminished quality of life.
Implementation Strategy
The resolution outlines a clear path to improving care:
- National Integration: Incorporating bleeding disorder management into broader NCD and maternal health policies.
- Essential Medicines: Encouraging member states to list life-saving therapies—including factor concentrates and novel non-factor treatments—on their National Essential Medicines Lists.
- Data and Awareness: Strengthening national data collection to better understand the prevalence of these disorders while simultaneously launching awareness campaigns to dismantle the stigma that often surrounds these conditions.
By elevating these disorders in global health policy, the Assembly is ensuring that rare, chronic conditions are no longer overlooked in the pursuit of "health for all."
Rebuilding Trust: The War on Health Mis- and Disinformation
The Strategic Roundtable: A New Public Health Threat
Perhaps the most contemporary challenge addressed by the Assembly was the proliferation of health misinformation and disinformation. A high-level Strategic Roundtable brought together government leaders, private sector technology stakeholders, the scientific community, and youth representatives to address what is now classified as a major public health threat.
The consensus was clear: mis- and disinformation are not merely peripheral "communication challenges." They are active barriers to the delivery of effective health interventions. When the public cannot distinguish between credible scientific evidence and manufactured falsehoods, health programs—including vaccination drives and chronic disease management—suffer.
Key Pillars of the Response
The Assembly identified several priorities for building resilient information ecosystems:
- Proactive Engagement: Moving beyond the "reactive" model of simply correcting false information to a "proactive" model of early, transparent communication.
- Empowering the Frontline: Health workers and trusted community leaders remain the most effective tools against misinformation. Supporting these individuals with the resources to communicate complex data is essential.
- Multisectoral Cooperation: Governments, social media platforms, and international health organizations must collaborate to improve the quality of information reaching the end-user.
- Scientific Integrity: Re-establishing the WHO’s role as a primary convener of evidence-based guidance is vital for restoring public trust in scientific institutions.
Implications for the Future of Global Health
The decisions taken at this World Health Assembly reflect a maturing of the global health agenda. The transition from the End TB Strategy to a post-2030 framework suggests an acknowledgment that infectious disease control must be agile and integrated into the broader architecture of Universal Health Coverage.
Simultaneously, the focus on NCDs like steatotic liver disease and the commitment to rare disorders like haemophilia signal a move toward addressing the full spectrum of human health. The Assembly has effectively broadened its mandate, recognizing that health is not merely the absence of disease, but the result of well-funded, equitable, and transparent systems.
However, the shadow of mis- and disinformation looms large over these objectives. The Assembly’s willingness to treat the information ecosystem as a public health utility is a necessary evolution. As the world moves toward 2030, the success of these resolutions will depend not only on the political will of individual nations but on the collective ability to protect the truth, bridge the funding gap, and ensure that the most vulnerable populations are not left behind in an increasingly complex and interconnected world.
The 2028 milestones will serve as the true test of these commitments. Until then, the global health community faces the arduous task of turning these resolutions into tangible, on-the-ground reality for the billions of people whose health and well-being depend on these policies.
About the Author
